Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06188234

The Prescription Patterns and Clinical Efficacy of Tenero Tab/Tenero M SR Tab

Observational Study on the Prescription Patterns and Clinical Efficacy of Tenero Tab/Tenero M SR Tab in Korean Type 2 Diabetes Mellitus Patients

Status
Recruiting
Phase
Study type
Observational
Enrollment
3,000 (estimated)
Sponsor
Hanlim Pharm. Co., Ltd. · Industry
Sex
All
Age
19 Years
Healthy volunteers

Summary

This study is to observe the prescription patterns and clinical efficacy of patients prescribed with Tenero Tab/Tenero M SR Tab for diabetes treatment in routine clinical practice.

Detailed description

This study is to observe the clinical efficacy by analyzing the prescription patterns in routine clinical practice and changes in HbA1c, FPG, PP2G, etc., of patients prescribed with Tenero Tab/Tenero M SR Tab for diabetes treatment. Additionally, the study intends to assess patient satisfaction based on these observations.

Conditions

Timeline

Start date
2022-12-27
Primary completion
2026-06-01
Completion
2026-06-01
First posted
2024-01-03
Last updated
2024-02-15

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT06188234. Inclusion in this directory is not an endorsement.